With Lil­ly's back­ing, a CRO with roots in Chi­na bags $150M round to fu­el glob­al growth

A re­named CRO with deep ties in the US and Chi­na has pulled in an­oth­er round of cap­i­tal.

Clin­Choice, for­mer­ly Foun­tain Med­ical De­vel­op­ment, has com­plet­ed a $150 mil­lion Se­ries E fund­ing round, us­ing the cash to con­tin­ue its planned ex­pan­sion.

Ac­cord­ing to Clin­Choice CEO Ling Zhen, the funds from the round will be part of a two-pronged strat­e­gy cen­tered around the com­pa­ny’s phys­i­cal growth. One area will be go­ing to­ward new so­lu­tions such as re­mote mon­i­tor­ing and da­ta an­a­lyt­ics but the oth­er area will be to­ward a ge­o­graph­ic ex­pan­sion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER